Dr. Kaag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
500 University Drive
UPC 3100
Hershey, PA 17033Phone+1 717-531-8521Fax+1 717-531-4475- Is this information wrong?
Summary
- Dr. Kaag is a board certified urologist who completed a urologic oncology fellowship at Memorial Sloan-Kettering Cancer Center in 2010. His practice focuses on the surgical management of patients with complex or advanced urologic cancers. He co-leads the Genitourinary Cancer Team at the Penn State Cancer Insitute and coordinates multidisciplinary cancer care for his patients. His clinical interests include bladder cancer, locally advanced kidney cancer, penile cancer, and testicular cancer. His research focuses on understanding barriers to recovery following radical cystectomy for bladder cancer.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2007 - 2010
- Penn State Milton S Hershey Medical CenterResidency, Urology, 2003 - 2007
- Penn State Milton S Hershey Medical CenterInternship, Transitional Year, 2002 - 2003
- Pennsylvania State University College of MedicineClass of 2002
Certifications & Licensure
- PA State Medical License 2002 - 2024
- NY State Medical License 2007 - 2010
- American Board of Urology Urology
Clinical Trials
Publications & Presentations
PubMed
- 69 citationsClinical Characteristics and Outcomes of Patients With Recurrence 5 Years After Nephrectomy for Localized Renal Cell CarcinomaAri Adamy, Kian Tai Chong, Daher C. Chade, James Costaras, Grace Russo
The Journal of Urology. 2011-02-01 - 43 citationsPreoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.Matthew Kaag, Landon Trost, R. Houston Thompson, Ricardo L. Favaretto, Vanessa Elliott
BJU International. 2014-11-01 - 203 citationsChanges in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative ChemotherapyMatthew Kaag, Rebecca L. O'Malley, Padraic O'Malley, Guilherme Godoy, Mang Chen
European Urology. 2009-04-01
Journal Articles
- Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect
- Predicted Versus Observed 30-Day Perioperative Outcomes Using the ACS NSQIP Surgical Risk Calculator in Patients Undergoing Partial Nephrectomy for Renal Cell CarcinomaBrian M Blair, Jay D Raman, Matthew G Kaag, International Urology and Nephrology
Press Mentions
- Detecting and Treating Urologic Cancers with Penn State Hershey Cancer InstituteSeptember 8th, 2015
Grant Support
- Enhancing Patient Resilience During Multimodal Therapy for Bladder CancerWells Fargo Barsumian Trust2013–2014
Professional Memberships
- Member
- Mid-Atlantic Section, AUAMember
- Urologic Oncology Research AllianceChair
Hospital Affiliations
- Penn State Hershey Childrens HospitalHershey, Pennsylvania
- Penn State Milton S. Hershey Medical CenterHershey, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: